Sarcoma  >>  sotigalimab (PYX-107)  >>  Phase 2
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
sotigalimab (PYX-107) / Pyxis Oncology
NCT03719430: APX005M and Doxorubicin in Advanced Sarcoma

Active, not recruiting
2
27
US
Doxorubicin, ADRIAMYCIN, APX005M, APX-005M
Alexander Z. Wei, MD, Apexigen America, Inc.
Soft Tissue Sarcoma
12/24
12/25

Download Options